PMID: 7012550Jan 1, 1980Paper

Cell growth and antimicrobial activity of mouse peritoneal macrophages in response to glucocorticoids, choleragen and lipopolysaccharide

Microbiology and Immunology
R T NozawaT Yokota

Abstract

Normal, thioglycollate-stimulated and BCG-activated mouse peritoneal macrophages were cultivated in vitro with the conditioned medium of mouse L-929 cells. The thioglycollate- and BCG-macrophages rapidly proliferated, whereas normal macrophages grew more slowly. A clear morphological difference between the three types of macrophages in the culture was observed. Glucocorticoids inhibited the growth of the macrophages at pharmacological concentrations. Other steroids, progesterone, diethylstilbestrol and testosterone in that order, had a far lower growth-inhibiting effect. Macrophages cultured with 10(-6) M dexamethasone had a reduced antimicrobial effect on Candida parapsilosis compared with that of the untreated cells. Choleragen had the same effect on the macrophages as glucocorticoids. The toxin inhibited growth at a concentration as low as 10 pg/ml and cells treated with 1 ng of choleragen per ml had decreased antifungal activity. Similarly, Escherichia coli lipopolysaccharide at 10 ng/ml inhibited the growth of thioglycollate-macrophages. However, macrophages incubated with the lipopolysaccharide had enhanced anticandida activity. Thus, the immunosuppressors glucocorticoid and choleragen inhibited both the increase in the n...Continue Reading

References

Jun 1, 1977·Experimental Cell Research·R T Nozawa, R L Guerrant
Dec 1, 1978·The Journal of Experimental Medicine·M J BerendtD P Kirstein
Jan 1, 1979·Infection and Immunity·D L Palmer, S N Zaman
Apr 1, 1978·The Journal of Experimental Medicine·B A van der ZeijstS Schlesinger
Oct 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·D Juy, L Chedid
Sep 1, 1977·Experimental Cell Research·B Morland, G Kaplan
Jun 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·W L McKeehanR G Ham
May 1, 1975·The Journal of Experimental Medicine·C C StewartC Adles
Jan 12, 1972·Nature: New Biology·J B HibbsJ S Remington
Jan 22, 1971·Nature·G W Sharp, S Hynie
Oct 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·D E SchaferN D Goldberg
Jul 1, 1969·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·U Hamberg
Jun 6, 1973·Nature: New Biology·H Lin, C C Stewart
Jun 1, 1974·Journal of the National Cancer Institute·R P ClevelandB Zbar
Jul 21, 1971·Nature: New Biology·P Alexander, R Evans
Sep 1, 1968·The Journal of Experimental Medicine·R van Furth, Z A Cohn
Mar 10, 1969·Biochemical and Biophysical Research Communications·I B Klein, J F Kirsch
Sep 1, 1962·The Journal of Experimental Medicine·G B MACKANESS

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.